Skip to content

Telerehabilitation for TMD

Telerehabilitation Effectiveness for Individuals With Temporomandibular Disorders (TMD): A Non-Inferiority Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05318313
Enrollment
207
Registered
2022-04-08
Start date
2022-06-17
Completion date
2024-07-01
Last updated
2026-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Masticatory Myofascial Pain, Temporomandibular Disorder, TMD Headache, TMJ Arthralgia, TMJ Disc Displacement Without Reduction, TMJ Disc Displacement With Reduction

Keywords

Temporomandibular Disorders, TMD, telerehabilitation, telehealth, physical therapy, PT

Brief summary

This study will compare after physical therapy for Temporomandibular Disorders (TMD) performed either in-person or virtually using telerehabilitation. Comparing diagnostic reliability and quality-of-life outcomes in each group will determine (based on a 10% margin) whether delivering physical therapy via telerehabilitation is as good as standard in-person care for these individuals. Long term outcomes including patient satisfaction, cost-effectiveness analysis, and functional status will describe the feasibility of telerehabilitation as a management intervention for this population.

Interventions

OTHERTelerehabilitation

The TR PT evaluation and follow-up visits will be performed via Zoom software

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* 18-70 years old * Referred to PT with ≥1 TMD subtype diagnosis * PI has no previous knowledge of the participant's diagnosis * Email access * Possession of any device that can be positioned for hands-free TR visits (TR group only) * Willingness and ability to comply with all study requirements and PT program * Able to provide informed consent

Exclusion criteria

* Non-English speakers * Permanent residence outside of the state of Minnesota (TR group only) * Women in the last trimester of pregnancy * Referred for post-surgical rehabilitation * Severe chronic pain as identified by level 4 classification on the GCPS * Current diagnosis or existence of the following conditions that can limit response to PT and participation in study activities: 1. Neuropathic pain 2. Fibromyalgia and/or generalized widespread pain on both sides of the body in ≥3 areas above and below the waist 3. Rheumatoid arthritis or juvenile idiopathic arthritis 4. Dystonia or other movement disorder 5. Fractures and/or recent jaw or facial trauma 6. Malignancies 7. Current substance abuse

Design outcomes

Primary

MeasureTime frameDescription
Specialist diagnosisMeasured directly after the PT evaluation (Day 1)Diagnosis will be determined by putting clinical assessment results into the Brief Diagnostic Criteria for TMD (Brief DC/TMD) algorithm and getting one or more of 7 possible diagnoses: TMJ arthralgia (joint), Masticatory myofascial pain (muscle), TMJ disc displacement with reduction (joint), TMJ disc displacement without reduction (joint), TMJ arthritis (joint), TMD headache (muscle), other (neither). The diagnosis will be measured as one of four options: 1. joint; 2. muscle; 3. both; or 4. neither.
Diagnostic agreementMeasured directly after the PT evaluation (Day 1)Agreement data for each subject will be collected comparing two specialist diagnoses: dentist and physical therapist. Agreement about the diagnostic category will be recorded as a binary yes/no measure.
The Oral Health Impact Profile for TMD summary score6 weeks after intervention onsetThe OHIP-TMD is a condition-specific quality-of-life scale with 22 items and a 0-4 scoring option for each item. A higher score means lower quality-of life. The summary score after 6 weeks will be compared to the baseline summary score, and a score decrease ≥6.9 units will be considered evidence of therapy success. The proportion of therapy success in each group will be used for non-inferiority comparison.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026